
CONMED Corporation(CNMD)
đ Dividend Highlights
Previous Payout History
53 payouts shownPay Date | Amount Per Share | Change vs Previous |
---|---|---|
April 4, 2025 | $0.20 | - |
January 3, 2025 | $0.20 | - |
October 4, 2024 | $0.20 | - |
July 5, 2024 | $0.20 | - |
April 5, 2024 | $0.20 | - |
January 5, 2024 | $0.20 | - |
October 5, 2023 | $0.20 | - |
July 5, 2023 | $0.20 | - |
April 5, 2023 | $0.20 | - |
January 5, 2023 | $0.20 | - |
October 5, 2022 | $0.20 | - |
July 5, 2022 | $0.20 | - |
April 5, 2022 | $0.20 | - |
January 5, 2022 | $0.20 | - |
October 5, 2021 | $0.20 | - |
July 6, 2021 | $0.20 | - |
April 5, 2021 | $0.20 | - |
January 5, 2021 | $0.20 | - |
October 5, 2020 | $0.20 | - |
July 6, 2020 | $0.20 | - |
April 6, 2020 | $0.20 | - |
January 7, 2020 | $0.20 | - |
October 7, 2019 | $0.20 | - |
July 5, 2019 | $0.20 | - |
April 5, 2019 | $0.20 | - |
January 7, 2019 | $0.20 | - |
October 8, 2018 | $0.20 | - |
July 5, 2018 | $0.20 | - |
April 5, 2018 | $0.20 | - |
January 5, 2018 | $0.20 | - |
October 5, 2017 | $0.20 | - |
July 5, 2017 | $0.20 | - |
April 5, 2017 | $0.20 | - |
January 5, 2017 | $0.20 | - |
October 5, 2016 | $0.20 | - |
July 6, 2016 | $0.20 | - |
April 5, 2016 | $0.20 | - |
January 5, 2016 | $0.20 | - |
October 5, 2015 | $0.20 | - |
July 6, 2015 | $0.20 | - |
April 6, 2015 | $0.20 | - |
January 5, 2015 | $0.20 | - |
October 6, 2014 | $0.20 | - |
July 7, 2014 | $0.20 | - |
April 7, 2014 | $0.20 | - |
January 6, 2014 | $0.20 | â˛33.33% |
October 4, 2013 | $0.15 | - |
July 8, 2013 | $0.15 | - |
April 5, 2013 | $0.15 | - |
January 7, 2013 | $0.15 | - |
October 5, 2012 | $0.15 | - |
July 6, 2012 | $0.15 | - |
April 5, 2012 | $0.15 |
Overall Dividend Trend
Dividend per share has changed by+33.33%over the past 13years(comparing first and last payout shown).
About CONMED Corporation
CONMED Corporation is a global medical technology company, primarily engaged in the development, manufacturing, and sale of surgical devices and equipment. Founded in 1970 and headquartered in Utica, New York, CONMED focuses on products for minimally invasive procedures in the areas of orthopedics, general surgery, gynecology, gastroenterology, and pulmonology. Led by CEO Curt R. Hartman since 2014, the company is committed to empowering healthcare providers to deliver better patient outcomes through innovative solutions. As of 2022, CONMED reported revenues of approximately $1.11 billion, reflecting its strong presence in the medical devices industry. The corporation operates both domestically and internationally, with a commitment to advancing healthcare technology and services worldwide.
Dividend data last updated:Sat, 17 May 2025 07:16:19 GMT. Financial data is indicative and provided for informational purposes only.